Shilpa Medicare Dilutes Stake in Koanna Healthcare Canada

Written By :  Parthika Patel
Published On 2026-01-15 09:23 GMT   |   Update On 2026-01-15 09:23 GMT
Advertisement

New Delhi: Shilpa Medicare Limited's wholly owned subsidiary Koanna Healthcare Canada Inc. has ceased to be a wholly owned subsidiary following the allotment of equity shares to an individual investor.

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, through an intimation dated 15 January 2026.

In its filing, Shilpa Medicare stated that Koanna Healthcare Canada Inc., a wholly owned subsidiary of the company, on 14 January 2026, allotted 2,84,21,020 equity shares aggregating to a total consideration of CAD 2,000. The allotment was carried out pursuant to a Share Sale–Purchase Agreement in favour of Mr. Steve N. Slilaty, an individual residing in Québec, Canada.

Advertisement

The company clarified that it had already made provisions for the said investment in its subsidiary and, therefore, there is no impact on Shilpa Medicare Limited’s current financials arising from this transaction. Consequent to the allotment of shares, Koanna Healthcare Canada Inc. ceased to be a wholly owned subsidiary of Shilpa Medicare Limited with effect from 14 January 2026.

Shilpa Medicare further disclosed that Koanna Healthcare Canada Inc. was not a material subsidiary of the company as defined under Regulation 16 of the SEBI LODR Regulations, 2015.

As per details provided in Annexure A, the income of Koanna Healthcare Canada Inc. for the last financial year stood at ₹34.33 lakh, contributing 0.03% to the consolidated income of Shilpa Medicare Limited, while its net worth was ₹46.09 lakh, accounting for 0.02%, based on audited financial statements as on 31 March 2025.

The date of execution and completion of the sale was reported as 14 January 2026, with the company noting that the share transfer may take normal time as per regular business practices. The filing also clarified that the transaction does not fall under related party transactions, was not part of any scheme of arrangement, and does not qualify as a slump sale.

Also Read: Shilpa Medicare ink pact to sell 31 percent stake in Sravathi Advanced Process Technologies for Rs 49.6 crore

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News